As the demographics of the population shift toward an increasingly aged society, the number of individuals with cancer increases and with it the need to give the most comprehensive possible health care delivery. Although much has been written about the specific therapy best suited for the various types of cancer and about the basic and clinical research which has dramatically improved treat ment, overall patient care requires attention to supportive care, which includes such items as pain management, the use of blood products, nutrition, and psychosocial needs. Yet infection remains the leading cause of death in cancer patients and is a major cause of morbidity and hospitaliza tion, making it a major aspect of the supportive care of cancer patients. It therefore deserves a full exposition. Bone marrow transplantation is increasingly being utilized as part of a therapeutic modality in the treatment of cancer patients. Transplantation patients are at such a particularly high risk of developing a wide variety of different types of infection, that they inevitably can serve as an excellent framework for discussion of all the types of infections that occur during the treatment of cancer. The patient undergoing allogeneic bone marrow transplantation is at particularly high risk of infection due to the major perturbations of host defenses, which include granulo cytopenia, cellular immune dysfunction, humoral immune dysfunction, blood product transfusions, and vascular access devices. Each of these perturbations results in a different set of infectious disease problems."

Intractable illnesses such as advanced cancer, AIDS, and chronic progressive neurological diseases present health-care professionals with an array of symptoms and ethical issues that demand extensive exploration and consideration. As the quest for advances in symptomatology continues, it is imperative to disseminate and integrate the knowledge currently available in palliative medicine. The International Symposium on Current Perspectives and Future Directions in Palliative Medicine was held in Tokyo in October 1997 to provide health-care professionals with a multidisciplinary approach for improving comprehensive palliative care. With invited speakers from North America, Europe, and Japan, the symposium focused on standard management and clinical trials of control of symptoms such as pain and cachexia, ethics in palliative medicine, the economics of health care, quality-of-life research, management of depression, and patient education.

Intractable illnesses such as advanced cancer, AIDS, and chronic progressive neurological diseases present health-care professionals with an array of symptoms and ethical issues that demand extensive exploration and consideration. As the quest for advances in symptomatology continues, it is imperative to disseminate and integrate the knowledge currently available in palliative medicine. The International Symposium on Current Perspectives and Future Directions in Palliative Medicine was held in Tokyo in October 1997 to provide health-care professionals with a multidisciplinary approach for improving comprehensive palliative care. With invited speakers from North America, Europe, and Japan, the symposium focused on standard management and clinical trials of control of symptoms such as pain and cachexia, ethics in palliative medicine, the economics of health care, quality-of-life research, management of depression, and patient education.